Diabetes Mellitus Flashcards

1
Q

What is Diabetes Mellitus (DM)? (+associated problems)

A

A group of metabolic diseases charcaterised by hyperglycemia resulting from defects in:

= insulin secretion / action / or both

Chronic hyperglycemia associated with long-term damage, dysfunction and failure of:

= eyes
= kidneys
= nerves
= heart
= blood vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What makes up the ominous octet of hyperglycaemia?

A
  1. Increased glucagon secretion (islet alpha cell)
  2. Impaired insulin secretion (islet beta cell)
  3. Decreased incretin effect
  4. Increased lipopolysis
  5. Increased glucose reabsoption
  6. Decreased glucose uptake
  7. Neurotransmitter
  8. Increased hepatic glucose production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is insulin?

A

= 51 a.a. peptide

= α and β chains linked by disulphide bonds

= produced in β cells of islets of langerhans in the pancreas

= synthesised as pre-proinsulin cleaved to proinsulin

= cleaved from C-peptide to release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the action of insulin in different organs?

A

Brain
= ↑ hunger
= ↓ hepatic glucose production
= ↓ lipoprotein production

Peripheral Muscle
= ↑ glucose metabolism
= ↑ glycogen synthesis
= ↑ muscle mass
= ↑ mitochondrial dysfunction

Adipose Tissues
= ↑ inflammation
= ↑ M2 to M1 macrophage switch
= ↑ glucose metabolism
= ↑ lypogenesis
= ↓ lippolysis

Livers
= ↓ glucose synthesis
= ↑ glycogen synthesis
= ↑ lipid accumulation
= ↑ inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does insulin act as an anabolic hormone?

A

= leads to glucose transport into muscle and fat cells

= promotes glycogen synthesis

= inhibits gluconeogenesis

= inhibits lipolysis

= promotes formation of triglycerides

= activates membrane sodium-potassium ATPases promoting K flux into cells

= stimulates cell growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the pathophysiology of DM?

A

Healthy
= insulin released and insulin receptor on surface of cell

Type 1
= pancreas fails to produce insulin

Type 2
= insulin produced
= BUT cells fail to respond to insulin properly (i.e. receptor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some symptoms of DM?

A

= always tired

= frequent urination

= sudden weight loss

= wounds that don’t heal

= always hungry

= sexual problems

= blurry vision

= vaginal infections

= numb or tingling hands or feet

= always thirsty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does endocrine control of glucose work?

A

INSULIN

Stimulation:
= glucose
= amino acids
= gastric inhibitory polypeptide (released from K cells of duodenum and jejunum)
= parasympathetic stimulation

Inhibition:
= glucagon
= sympathetic stimulation

GLUCAGON

Stimulation:
= low glucose
= amino acids
= sympathetic stimulation
= adrenaline

Inhibition
= insulin
= gastric inhibitory polypeptide (GIP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some diagnostic tests for DM?

A

A1C

Fasting plasma glucose

2-hr plasma glucose during OGTT

Random plasma glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some stats about DM in the UK?

A

6% of adults (3.2 million) diagnosed with DM in UK

Type 1 DM
= 10% of total
= prevalence in <19 y.o = 1 in 430-450
= prevalence in <14 y.o = 24.5 in 100,000
= peak diagnosing age = 10-14 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the different classifications of DM?

A

Type 1
= autoimmune
= rapidly develops
= mostly diagnosed in young children
= insulin needed immediately

Type 2
= not autoimmune
= develops slowly
= diagnosed mostly in adults
= insulin not needed immediately - other medications

Gestational
= diabetes during pregnancy (2nd/3rd trimester)
= goes away after pregnancy
= treated through diet and exercise, sometime insulin
= increases risk of type 2 later in life

MODY
= maturity onset diabetes of the young
= mimics type 2 (but in young people)
= strong genetic risk factor
= insulin not always needed

LADA
= latent autoimmune diabetes of adulthood
= form of type 1 but in adulthood
= can be misdiagnosed

(Type 3)
= controversial
= suggests alzheimers could be called type 3 sue to insulin resistance seen

EXTRA READING - Type 3
= insuline resistance and insulin-degrading enzyme deficiency in brain of AD patients
= unable to use glucose effectively = leads to amyloid-plaques
= not widely accepted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Summarise the causes of T1DM.

A

Immune / Autoimmune

Environmental
= intrauterine
= early life
= geography

Genetics
= HLA /MHC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the genetics of T1DM?

A

85 % of T1DM patients have no affected 1st degree family relatives

Risk among 1st degree relatives of T1DM is approx 15x greater than general population

EXTRA READING
= HLA (human leukocyte antigen) = chromosome 6
= also genes that regulated immune function (e.g. CTLA-4, PTPN22, INS =)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some environmental risk factors for T1DM?

A

Viruses
= coxsackie B
= cytomegalovirus
= echo
= epstein-barr
= mumps

Diet
= cow’s milk
= caffeine
= nitrates

Lifestyle
= exposire to toxins
= stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the geographical variation and incidence of T1DM?

A

Incidence varies worldwide
= risk increases with distance from equator

Relocating from region of low to high incidence
= increases risk of T1DM
= suggests environmental factors
= BUT still variations in incidence between neighbouring areas of similar latititude
= suggests other contributing factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the pathophysiology of T1DM?

A

= cellular mediated autoimmune destruction of insulin producing β cells in pancreatic islets of langerhans

= autoantibodies
to GAD, islet cell, IA-2 and zinc transporter 8 found in 96% of patients at diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is T2DM?

A

= usually presents in middle age / eldely

= often with a family history

= strong links with obesity and hypertension

= associated insulin resistance at cellular level

= inadequate insulin produced to overcome resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the aetiology of insulin resistance?

A

= defective insulin mediated glucose uptake

Genetics
= islet cell development
= insulin release
= abnormal insulin receptor
= abnormal signalling proteins

Environment
= obesity
= diet
= ageing
= medication

Leads to T2DM
= hyperglycaemia
= lipolysis
= lipid abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How is obesity linked to T2DM?

A

Weight gain of 7-11kg over 18 years
= 2-fold increase in risk of diabetes
= prevalence in adults is rising = global burden

As obesity increases
= so does insulin resistance and hyperinsulinaemia

= linked to inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the evidence for inflammation being a link between obesity and T2DM?

A

ADIPONECTIN (adipocyte-derived cytokine)
= improved lipid profiles, better glycaemic control
= reduced markers of inflammation in diabetic patients
= inversely associated with risk for diabetes in nondiabetic population

TNF-α (pro-inflammatory cytokine)
= TNF-α mRNA adipose tissue positively correlated obesity and hyperinsulinaemia
= blocking TNF-α antibodies improves glucose utilisation in obese rodents
= patients with rheumatoid arthritis treated with anti-inflammatory TNF inhibitors have lower incidence of diabetes

CXCL5 (pro-inflammatory, expressed in macrophage fraction white adipose tissue)
=binding to receptor CXCR2 reduces insulin-stimulated glucose uptake in muscle
= serum level CXCL5 higher in obese individuals / insulin-resistant obese compared to non-insulin-resistant obese individuals
= CXCL5 concentrations decrease with weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the core defects in T2DM?

A

Insulin Resistance
(+ hyperinsulinaemia with normal glucose tolerance)

Impaired β-cell function

= both lead to insulin resistance and declining insulin levels with impaired glucose tolerance

= T2DM

22
Q

What are the major metabolic defects in T2DM?

A

Peripheral insulin resistance in fat
= ↑ lipolysis
= ↓ clearance of TG
= ↓ glucose uptake
= ↓ glucose utilisation
= ↑ FFA

Peripheral insulin resistance in muscle
= ↓ clearance of TG
= ↓ glucose uptake
= ↓ glucose utilisation
= ↑ VLDL production

Hepatic insulin resistance
= ↑ glucose output
= ↑ glucose utilisation
= ↓ glucose uptake

Relative insulin deficiency
= insulin secretion not sufficient to overcome insulin resistance

23
Q

What is the progression of DM?

A

Start with normal glucose tolerance

Then impaired glucose regulation

Then DM:
- can be non insulin requiring
- insulin requiring for control
- insulin requiring for survival (only T1DM)

24
Q

What are some comparisons between T1DM and T2DM?

A
25
Q

How to differentiate between T1DM and T2DM?

A

Islet autoantibody testing
= usually positive in T1DM at time of diagnosis
= BUT less sensitive with time

Serum c-peptide
= <0.2 nmol/l diagnostic of T1DM

Urinary c-peptide to creatinine ratio

26
Q

What is monogenic diabetes?

A

= approx 2% of diabetes

= arises from specific genetic mutations

MIDD
= maternally inherited diabetes and deafness
= mutation of mitochondrial DNA at nucleotide 3243

MODY
= maturity onset diabetes of the young
= mutations in glucokinase
= mutations in HNF1α, HNF1β, HNF4α genes

Neonatal diabetes
= mutations in sulphonylurea receptor

Insulin action - resistance
= e.g. leprachaunism

27
Q

What are some other important causes of diabetes?

A

Endocrine disease
= Cushing’s disease (cortisol excess)
= Acromegaly (growth hormone excess)
= Phaeochromocytoma (catecholamine excess)

Secondary diabetes
= pancreatic disease

Drugs, toxins
= steroids, thiazides

Gestational diabetes

28
Q

What are some complications of DM?

A

Acute
= hypoglycaemia (adrenic / sympathetic symptoms)
= DKA (diabetic ketoacidosis)
= HHS (hyperosmolar hyperglycaemic state)

Chronic
= microvascular
(e.g. eye disease, renal failure, diabetic foot, nerve disease)
= macrovascular
(e.g. stroke, heart damage, arteriosclerosis)

29
Q

What is DKA?

A

= Diabetic Ketoacidosis

D = hyperglycaemia or normoglycaemia in known diabetics (>11mmol)

K = ketosis (>3 mmol/L / known diabetic)

A = metabolic acidosis (HCO3 <15 or pH <7.3)

= dehydration (fluid deficit 100ml/kg)

30
Q

What are the mechanisms of the chronic complications in DM?

A

Macrovascular
= hyperlipidaemia
= hypertension
= endothelial dysfunction

Microvascular
= genetics - familial clustering of complications
= polyol production - sorbitol
= glycation of proteins
= protein kinase C activation

Complications increase with age
= genetic susceptibility
= glycaemic control
= duration of diabetes
= blood pressure
= lifestyle
= medical care

31
Q

What are the biochemical factors in microvascular function?

A

Hyperglycaemia
= leads to AGE formation (Advanced glycation end products)

which then leads to
= altered function of protein
AND
= receptor binding (RAGE) = proinflammatory
(leading to increased cytokines, adhesion molecules)

which all lead to microvascular complications
= change in blood flow, coagulation, vascular cell growth, extra vascular protein production, endothelial permeability

32
Q

What are some chronic complications of DM present at diagnosis?

A

50% of newly presenting patients with type 2 diabetes already have one or more complications at diagnosis

= ischaemic skin changes to feet (6%)
= perivascular vascular disease (3%)
= absent foot pulses (13%)
= stroke or transient ischaemic attack (1%)
= hypertension (35%)
= retinopathy (21%)
= abnormal ECG (18%)
= myocardial infarction (1%)
= renal impairment (3%)

33
Q

What is Diabetic Nephropathy?

A

= diabetic kidney disease

= 30% of people with T2DM will have some evidence of kidney disease

= 16% of all new patients needing renal replacement therapy have diabetes

Normal renal function

then Microalbuminuria (20-200 mg/L)

= Proteinuria >200 mg/L

= Glomerular death (increased serum creatinine, eGFR)

= renal failure (dialysis needed)

34
Q

What is Diabetic Retinopathy?

A

= diabetic eye disease

= most common cause of blindness ages 30-69

= 20% of T2DM patients have retinopathy at diagnosis

= after 15 years, 2/3 have background retinopathy

35
Q

What is Diabetic Neuropathy?

A

= diabetic nerve disease

= ulceration neuropathy = leads to loss of sensation injuries = vascular disease = tissue death = impaired healing

= 15% of DM patients develop foot ulcers
= 5-15% of these people need amputations

36
Q

Summarise the methods to monitor glycaemic control?

A

Symptoms

Urinalysis

Capillary Glucose

HbA1 (HbA1c)

Interstitial glucose
= continuous glucose monitoring
= flash glucose monitoring

37
Q

What is urine glucose testing?

A

= dip sticks into urine

= crude method

= now largely redundant due to development of capillary glucose monitoring

38
Q

What is capillary glucose testing?

A

= finger prick glucose monitoring

= can be performed multiple times a day

= critical for good control in T1DM

= ~£10 for 50 tests

39
Q

What is continuous glucose monitoring (CGM)?

A

= sensory monitors interstitial glucose
(levels ~15 mins behind blood glucose)

= data wirelessly transmitted to insulin pump / monitor

= pump / monitor can alarm when glucose levels trending high / low

= ~£50 for 5 days of monitoring (expensive)

= can produce closed loop system where it automatically adjusts = artificial pancreas

40
Q

What is Flash Glucose Monitoring?

A

= monitors interstitial glucose

= sensor worn on arm for 14 days

= data transmitter to monitor when swiped over sensor

= can store up to 8 hours of data

= monitor can show current glucose, glucose variation over last 8 hours and glucose trend

= latest upgrade will alarm to warn of hypoglycaemia

= less expensive than CGM = ~£100 for 28 days (on NHS)

41
Q

What are HbA1C assays?

A

= >30 assay methods

e.g. TOSOH G7
= automated HPLC
= 2.2min/ sample
= total seperation b/w labile and stabel HbA1c %
= total sepration b/w HbA0 and variants HbS,C,D

Targets
T1DM
= <6.5% (48 mmol/mol)

T2DM
= lifestyle and diet managed = 48 mmol/mol (6.5%)
= single drug not hypoglycaemia associated (e.g. metformin) = 48 mmol/mol (6.5%)
= drug associated with hypoglycaemia (e.g. suphonylurea) = 53 mmol/mol (7.0%)

42
Q

What are the aims of treatment in DM?

A

= avoidance / reduction of symptoms of hyperglycaemia

= restore metabolism and glucose homeostasis to as near normal as possible

= avoidance / reduction of hypoglycaemia

= delay / prevent development of long term complications

43
Q

What are insulin regimens for T1DM?

A

Most on ‘basal-bolus’ regimes
= long acting insulin analogue (for all day)
AND
= prandial rapid acting insulin (adjusting according to carbohydrate content of meals and blood sugar levels)

More patients being treated with
= rapid acting insulin administered subcutaneously by programmable insulin pump

Education
= on carbohydrate counting provided by dieticians and education courses e.g. DAFNE

44
Q

What is insulin pump therapy for T1DM?

A

= insulin pumped continuously through subcutaneous plastic cannula

= pump programmable to vary insulin administration at different times of the day

= insulin boosted at meal times according to carbohydrate content of meals

= can be integrated with CGM to alarm with warnings of hypo / hyperglycaemia

= artificial pancreas = glucose modelling data and CGM to auto adjust (closed loop system)

45
Q

What are the benefits of intensive treatment for DM?

A

e.g. DCCT trial with a 9 year follow up

Intensive
= Hba1c = 7.2%
= mean glucose = 8.6 mmol/L
= retinopathy = 12%
= microalbuminuria = 16%

Conventional
= Hba1c = 9.1%
= mean glucose = 12.8 mmol/L
= retinopathy = 54%
= microalbuminuria = 24%

= differences persisted for 10 years

46
Q

What are other important considerations in improving outcomes in patients with DM?

A

= prevention

= patient education (diet , self-monitoring)

= physical exercise

= smoking cessation

= alcohol intake

= treatment of hypertension

= treatment of hyperlipidaemia

= weight loss

47
Q

What are some examples of drug treatments (+what do they affect)?

A

Metformin

Alphaglucosidase inhibitors
= glucose absorption

Thiazolidinediones
= glucose uptake and utilisation

Sulfonylureas / Meglitinides
= pancreas, insulin production

48
Q

What is Metformin?

A

= only available biguanide

= increases glucose uptake and utilisation by target tissues

= therefore decreases insulin resistance

= decreases hepatic gluconeogenesis

= requires insulin for action
(therefore does NOT work for T1DM)
(BUT does NOT promote insulin secretion)

= mechanism of action not fully understood

= never causes hypoglycaemia

= can cause weight loss

49
Q

What are sulfonylureas?

A

= bind to and close ATP-sensitive K+ channels on cell membrane of pancreatic β cells

= depolarises cell by preventing K+ from exiting

= opens voltage-gated Ca2+ channels (rise in intracellular Ca2+)

= increased fusion of insulin granulae with cell membrane

= increased secretion of (pro)insulin

= can cause hypoglycaemia (if patient does not eat when taking medication)

= can cause weight gain (increased hunger)

50
Q

What are DPP-IV inhibitors / GLP-1 agonists?

A

GLP-1 agonists = analogue of DPP-IV inhibitors
(stay longer BUT has same effect)

= DDP-IV = inactivate GLP-1 and GIP (incretins - released from gut in response to food intake)
= inhibit DDP-IV = increase incretin levels
= stimulates insulin secretion from pancreas
= reduced glucagon secretion
= slows down gastric emptying
= glucose dependent = requires person to eat = less hypoglycaemia
= e.g. sitagliptin, saxagliptin

= GLP-1 agonists mimic GLP-1 and produced same effects
= e.g. exenatide, liraglutide

= have large effect on slowing absorption and feeling full for longer
(therefore can cause MASSIVE weight loss)

51
Q

What are SGLT2 inhibitors?

A

Normally = 90% of glucose is reabsorbed by SGLT2

= these drugs inhibit SGLT2
= prevents glucose from being reabsorbed
= increased glucose excretion in the urine
= reducing in blood glucose levels

= can also lead to weight loss and decreased blood pressure

= side effects include increased UTIs, occasionally ketoacidosis